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Epidermal RelA Specifically Restricts Contact
Allergen–Induced Inflammation and Apoptosis in Skin
Snehlata Kumari1, Benjamin Herzberg1, Ruth Pofahl1, Thomas Krieg1 and Ingo Haase1
Strong inhibition of NF-kB signaling in the epidermis results in spontaneous skin inflammation in mice and men.
As there is evidence for linkage between polymorphisms within the NF-kB signaling pathway and human
inflammatory skin phenotypes, we asked whether partial functional inhibition of NF-kB signaling in epidermal
keratinocytes can modulate clinically relevant skin inflammation. We therefore mutated rela specifically in the
epidermis of mice (RelAE-MUT mice). These mice show no inflammatory phenotype. Induction of contact allergy,
but not croton oil–induced irritant dermatitis, resulted in stronger ear swelling and increased epidermal thickness
in RelAE-MUT mice. Both contact allergen and croton oil treatment led to increased expression of calgranulins A
and B (S100A8/ A9) in RelAE-MUTmice. Epidermal hyperproliferation in RelAE-MUTmice was non-cell autonomous as
cultured primary epidermal keratinocytes from RelAE-MUT mice showed reduced proliferation compared with
controls. These results demonstrate that epidermal RelA specifically regulates delayed-type hypersensitivity-
induced skin inflammation. In addition, we describe here an essential but nonspecific function of RelA in the
protection of epidermal keratinocytes from apoptosis. Our study identifies functions of NF-kB signaling in the
epidermis and corroborates a specific role of epidermal keratinocytes in the regulation of skin inflammation.
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INTRODUCTION
Several human skin diseases have been associated with
alterations in the activity of the NF-kB pathway (Smahi
et al., 2000; Zonana et al., 2000; Courtois et al., 2003;
Janssen et al., 2004; Orstavik et al., 2006; Vinolo et al., 2006).
This association is also supported by several studies in mice
showing that both activation (Beg et al., 1995a; Klement et al.,
1996; Rebholz et al., 2007) and inhibition (Weih et al., 1995;
Barton et al., 2000; Pasparakis et al., 2002; Nenci et al., 2006)
of NF-kB signaling can lead to skin inflammation.
Only one known human disease shows spontaneous skin
inflammation owing to strong NF-kB inhibition in epidermal
keratinocytes caused by inhibitory mutations in NFkappaB
essential modulator (NEMO): incontinentia pigmenti (Schmidt-
Supprian et al., 2000; Smahi et al., 2000). Other disease-
associated polymorphisms within the tumor necrosis factor-
NF-kB signaling pathway do not seem to cause spontaneous
inflammation. For e.g., epidermis-specific deletion of A20
(TNFAIP3), a regulator of NF-kB activity, does not cause skin
inflammation (Lippens et al., 2011). To investigate how such
polymorphisms could contribute to the expression of an
inflammatory skin phenotype, we have asked whether an
epidermis-specific mutation that is functionally relevant to
signal transduction via NF-kB but does not cause an overt
inflammatory skin phenotype could modify a clinically
relevant type of skin immune response.
NF-kB is a ubiquitous transcription factor that consists of
homo- or hetero-dimeric subunits of RelA/p65, RelB, cRel,
NF-kB2/p52, and NF-kB1/p50 (Verma et al., 1995). Previous
reports have suggested that embryonic keratinocytes isolated
from mice with complete deficiency of the NF-kB subunit
RelA before E15.5 show cell autonomous hyperproliferation
in vitro and in vivo (Zhang et al., 2004).
The presence of NF-kB subunits, such as RelA, in the
epidermis inhibits epithelial cell death induced by Fas ligand,
tumor necrosis factor-a, and microbes (Qin et al., 1999; Seitz
et al., 2000; Li et al., 2001). One mechanism by which NF-kB
protects cells from apoptosis is the induction of expression of
anti-apoptotic genes such as cellular inhibitors of apoptosis and
X-linked inhibitors of apoptosis (XIAPs) (Barkett and Gilmore,
1999; Bowen et al., 2003; Hussain et al., 2011; Meng et al.,
2012). One of the nuclear proteins binding to endogenous
XIAP and antagonizing its anti-apoptotic functions is XIAP-
associated factor 1 (XAF1). Overexpression of XAF1 sensitizes
cells to apoptosis (Liston et al., 2001) and reduced expression
of XAF1 is frequently seen in tumors and cancer cell lines (Ng
et al., 2004; Plenchette et al., 2007; Tu et al., 2009).
Contact hypersensitivity/delayed-type hypersensitivity (DTH)
is an immune reaction during which cytotoxic T lymphocytes
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attack epidermal keratinocytes in response to an antigen
(Watanabe et al., 2002). The role of skin-resident cells in
the modulation of this response has not been thoroughly
investigated. Nickel has been shown to induce NF-kB in
endothelial cells, facilitating the recruitment of leukocytes to
the skin (Goebeler et al., 1995, 2001; Bell et al., 2003; Zhang
et al., 2010). In another model of contact allergy, RelB
knockout mice showed reduced edema and inflammatory
response (Weih et al., 1995).
Cytokines of the S100 family, S100A8 (Calgranulin A) and
S100A9 (Calgranulin B), are small calcium-binding proteins
expressed by immune cells such as neutrophils and monocytes
as well as by keratinocytes. They are associated with epider-
mal hyperproliferation during wound healing and in psoriasis
(Thorey et al., 2001; Eckert et al., 2004). Calgranulins trigger
the release of other pro-inflammatory factors from keratino-
cytes and promote their growth (Nukui et al., 2008).
Using mice with partial functional inhibition of RelA in the
epidermis, we describe here that NF-kB activity in epidermal
keratinocytes is specifically required to restrict the severity of a
clinically relevant inflammatory skin phenotype.
RESULTS
Generation of mice with epidermis-specific expression of mutant
RelA
We generated mice with epidermis-specific expression of a
truncated, nonfunctional RelA mutant (RelAE-MUT mice) by
crossing mice carrying floxed rela alleles (Algul et al., 2007)
with transgenic mice expressing Cre recombinase under the
control of K14 promoter (Hafner et al., 2004). Western blot
analysis of epidermal lysates from RelAE-MUT mice, but not
from control mice, showed expression of a truncated version
of RelA (Figure 1a), which has been described previously (Algul
et al., 2007). RelAE-MUT mice were indistinguishable from wild-
type controls (Figure 1b). Histological and immunohistological
analyses revealed normal skin structure and normal expression
of epidermal differentiation markers keratin 6 (K6), keratin 14
(K14), keratin 10 (K10), and Loricrin (Figure 1c and d).
Inflammatory response in the absence of epidermal RelA activity
RelA is known to control inflammatory functions in immune
cells (Pittet et al., 2011; Powolny-Budnicka et al., 2011). To
understand the function of RelA in epidermal keratinocytes
during inflammation, we induced a DTH reaction against
1-fluoro-2,4-dinitrobenzene (DNFB) in control and RelAE-MUT
mice. Ear thickness was measured at sensitization and challenge
as well as at 24, 48, 72, 96, and 120 hours after challenge. Both
control and RelAE-MUT mice showed increasing ear thickness
with time after challenge until 96 hours. At 120 hours after
challenge, ear thickness declined (Figure 2a). In RelAE-MUT
mice, however, ear thickness was significantly higher at all time
points after challenge as compared with control mice (Figure 2a).
Similar results were obtained when we used oxazolone as an
antigen (Supplementary Figure S1d online), indicating that the
differential response in RelAE-MUT mice is not DNFB specific,
but a broader phenomenon in the DTH response.
We asked whether enhanced inflammation in RelAE-MUT
mice was specific to the DTH response, and therefore induced
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Figure 1. Absence of functionally active RelA from the epidermis does not cause a pathological skin phenotype. (a) Western blot of RelA protein on
epidermal lysates from control and RelAE-MUT mice. DRelA: truncated, functionally inactive mutant of RelA. (b–d) Macroscopic (b) and histological (c) appearance
and keratin 10, keratin 14, and Loricrin staining (d) of skin of control and RelAE-MUT mice at P 60. Scale bars in (b, c) are 100mm. H&E, hematoxylin and eosin.
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an irritant contact dermatitis using croton oil. Ear thickness
was measured in control and RelAE-MUT mice until 96 hours
after treatment. In contrast to the DTH response upon
DNFB or oxazolone challenge, ear thickness after croton oil
application was comparable in control and RelAE-MUT mice at
all time points measured (Figure 2b). These results show that
the role of epidermal RelA in the regulation of skin inflamma-
tion is variable depending on the type of the inflammatory
response.
To exclude an effect of epidermis-specific functional RelA
deficiency in the sensitization process to DNFB, we isolated
spleen and inguinal lymph node cells from vehicle (aceto-
ne:olive oil) and DNFB-sensitized mice. In vitro antigen
stimulation of these cells after 24 hours showed similar
numbers of IFN-g-producing cells in both control and
RelAE-MUT mice (Supplementary Figure S1e online), indicating
that functional RelA deficiency in the epidermis did not
influence sensitization to DNFB.
To determine whether hyperplasia of the epidermis
(acanthosis) contributes to increased ear thickness in RelAE-
MUT mice, epidermal thickness of challenged control and
RelAE-MUT mice was measured microscopically. This measure-
ment revealed that the epidermis of RelAE-MUT mice was about
two times thicker than that of control mice (Figure 2a). This
difference was statistically significant. This increased epider-
mal thickness in RelAE-MUT skin was due to keratinocyte
hyperproliferation, as revealed by a marked increase in
BrdU-positive epidermal keratinocytes compared with control
mice (Supplementary Figure S1a online). We thus conclude
that the observed increase in ear thickness in RelAE-MUT mice
is due to both stronger ear swelling and increased epidermal
thickness.
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Figure 2. Loss of epidermal RelA activity aggravates inflammation and causes increased epidermial thickness in a delayed-type hypersensitivity response.
Ear thickness measurement after DNFB (0–120 h) or croton oil challenge (0–96 hours) as well as hematoxylin and eosin staining of ear sections and morphometric
measurements of epidermal thickness at 96 hours after DNFB challenge (a) or croton oil application (b) in control (DNFB n¼ 16; croton oil n¼ 14) and
RelAE-MUT (DNFB n¼ 17; croton oil n¼ 16) mice. Experimental control groups of control (n¼8) and RelAE-MUT (n¼6) mice were sensitized with acetone:
olive oil and challenged with DNFB. Scale bar¼ 100mm. NS, not significant.
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Reduced in vitro keratinocyte proliferation in the absence of
RelA activity
Previous studies have suggested a cell autonomous function of
NF-kB transcription factors in restricting keratinocyte pro-
liferation before terminal differentiation (Zhang et al., 2004).
To address the question whether increased keratinocyte
proliferation in RelAE-MUT mice was cell autonomous, we
isolated primary epidermal keratinocytes from control and
RelAE-MUT mice and obtained growth curves. Expression of
mutant RelA was confirmed by western blot analysis
(Figure 3a). Surprisingly, the growth rate of RelA-deficient
keratinocytes in culture as well as BrdU incorporation were
lower in RelA-deficient keratinocytes than in control kerati-
nocytes (Figure 3b and c). Thus, RelA-deficient keratinocytes
show reduced proliferation in culture. We therefore con-
clude that the increased epidermal thickness in RelAE-MUT
mice is not caused by cell autonomous keratinocyte
hyperproliferation.
Differential regulation of S100 proteins in RelAE-MUT mice
As the hyperproliferation of RelAE-MUT keratinocytes was not
cell autonomous, we asked whether differential immune cell
recruitment to the inflamed ear skin of RelAE-MUT mice could
account for the observed differences. We stained sections of
challenged ears with antibodies against surface markers of
inflammatory cells, i.e., myeloid cells (CD11b), macrophages
(F4/80), and T lymphocytes (CD3). In these stainings, both
control and RelAE-MUT mice showed a comparable pattern
and density of immune cell infiltration after 96 hours
(Supplementary Figure S1b online).
We therefore asked whether there were functional differ-
ences in the production of inflammatory mediators present in
the skin during the DTH response. To identify such mediators,
we performed microarray analysis on RNA from ear samples
at 48 hours after challenge. This analysis revealed that two
stress-induced proteins, S100A8 and S100A9, were upregu-
lated in challenged ears of RelAE-MUT mice in comparison with
challenged ears of control mice. This upregulation was
confirmed by western blot analysis of protein lysates from
DNFB-challenged ears at 48 and 96 hours (Figure 4a) and
by immunostaining of skin sections at 96 hours (Figure 4b).
In addition to higher numbers of S100A8-positive cells
in the dermis, epidermal keratinocytes of RelAE-MUT mice also
consistently showed a stronger signal for S100A8 than did
keratinocytes of control mice (Figure 4b). Untreated control
and RelAE-MUT mice did not show S100A8- and S100A9-
positive cells in the skin (data not shown).
To investigate whether the upregulation of S100A8/A9 was
DTH specific, we analyzed croton oil–treated ears after
48 hours and found increased expression of both S100A8
and S100A90 in RelAE-MUT mice (Figure 4c). This shows that
the absence of RelA function from epidermal keratinocytes
results in increased production of S100A8 and S100A9 upon
inflammation, regardless of the pro-inflammatory stimulus.
Enhanced apoptosis of RelAE-MUT keratinocytes in vivo and
in vitro
The NF-kB activity has been implicated in the regulation of
apoptosis in keratinocytes and many other cell types (Alcamo
et al., 2001; Li et al., 2001). We therefore investigated the
consequences of epidermal RelA deficiency for DTH-induced
and croton oil–induced keratinocyte apoptosis.
At 96 hours after DNFB challenge or oxazolone challenge
or croton oil application, the epidermis of RelAE-MUT mice
contained higher numbers of keratinocytes with eosinophilic
cytoplasm and hyperchromatic, pycnotic nuclei as compared
with those in control mice (Figure 5a; Supplementary Figure
S1d online). These cells were morphologically highly similar
to sunburn cells observed after UV irradiation of the skin
(Bayerl et al., 1995). Staining for cleaved, active caspase-3
confirmed an increased number of apoptotic epidermal
keratinocytes in both DNFB-challenged and croton oil–treated
RelAE-MUT mice as compared with DNFB-challenged controls
(Figure 5b). RelAE-MUT mice without any treatment did not
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show sunburn cells or caspase-3-positive cells in the epider-
mis, similar to control mice (Supplementary Figure S1c
online). This shows that apoptosis of epidermal keratinocytes
is enhanced in the inflamed skin of RelAE-MUT mice, regardless
of the nature of the pro-inflammatory stimulus.
Although it is well established that the activity of the NF-kB
signaling pathway protects cells from apoptosis, the mechan-
isms involved remain unidentified. In our microarray analysis
mentioned before, we found that the XAF1 was differentially
expressed in the DNFB-challenged ears of RelAE-MUT mice and
control mice. This differential expression of XAF1 was con-
firmed by western blot analysis of protein lysates of ears of
RelAE-MUT and control mice 48 and 96 hours after DNFB
challenge and also after croton oil treatment (Figure 5c).
We conclude that, in the absence of RelA from epidermal
keratinocytes, XAF1 is upregulated in inflamed skin. This
could be a cause for the observed increase in apoptosis in
RelA-deficient epidermal keratinocytes.
DISCUSSION
The NF-kB signaling pathway is known to be a major regulator
of organ inflammation. It is thus not surprising that genome-
wide association studies in the chronic inflammatory skin
disease psoriasis have revealed linkage with polymorphisms
within this pathway (Nair et al., 2009). These studies cannot
explain, however, in which way these polymorphisms could
functionally contribute to the pathogenesis of skin inflamma-
tion. In this study, we have used genetically modified mice in
which exons 7–10 of the rela gene were deleted, resulting in
the translation of a truncated, nonfunctional mutant of RelA
and thereby partial inhibition of NF-kB signaling (Algul et al.,
2007). Unlike other inhibitory mutations within the NF-kB
signaling pathway (Pasparakis et al., 2002; Nenci et al., 2006),
this epidermis-specific genetic modification does not result in
the spontaneous development of an inflammatory skin
phenotype. To analyze whether such partial inhibition of
NF-kB signaling in epidermal keratinocytes can contribute to
the pathogenesis of clinically relevant skin inflammation, we
have tested the effect of the rela mutation on the outcome of
DTH and irritative responses of the skin.
To our surprise, RelAE-MUT mice did not show an overt
phenotype. Previous work has suggested that, in the epider-
mis, NF-kB is responsible for the regulation of the transition of
basal, proliferating keratinocytes to suprabasal, differentiating
cells. This has been concluded from in vitro experiments
with cultured epidermal keratinocytes retrovirally transduced
with DNA fragments coding for mutant variants of the
NF-kB proteins p50 and p65 (Seitz et al., 1998). In addition,
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transplanted RelA-deficient embryonic keratinocytes gave rise
to a hyperplastic epidermis in severe combined immuno-
deficient mice (Zhang et al., 2004). In contrast to the results
previously achieved with cultured and transplanted keratino-
cytes, our mice with epidermis-specific abrogation of RelA
function (RelAE-MUT mice) did not show a disturbed balance of
keratinocyte proliferation and differentiation within the
epidermis. The absence of an overt disturbance in epidermal
homeostasis is also a feature of mice in which RelA was
deleted in an epidermis-specific manner using a different
targeting strategy (Manolis Pasparakis, personal communi-
cation). In addition, epidermal keratinocytes with inhibited
RelA function in culture exhibited a decrease, instead of
increase, in cell proliferation and incorporation of BrdU as
compared with control keratinocytes. This shows that RelA is
not required for the growth arrest of epidermal keratinocytes
but could even have a growth-promoting role, at least in
culture. In addition, RelA function is dispensable for the
formation of a normal epidermis. This obvious difference to
the previously published results can be explained in different
ways: first, expression of dominant negative NF-kB mutants
using retroviral constructs probably leads to a more broad
suppression of NF-kB activity, whereas the loss of RelA
function in RelAE-MUT mice is more specific and would
allow for compensation by other NF-kB subunits, e.g., c-Rel.
Second, transplantation of skin inevitably causes a wound-
healing reaction of the skin, which creates an extracellular
environment entirely different from resting skin. Therefore,
our knockout model is more representative for resting skin
than a transplantation model. On the other hand, we show
that, within an inflammatory environment, the RelA-negative
epidermis shows a different behavior than wild-type epi-
dermis, i.e., hyperplasia. Thus, our results are not necessarily
inconsistent with those of Zhang et al. (2004) as absence or
functional impairment of RelA in an altered cytokine milieu
shows epidermal hyperplasia in both models. This would also
be in agreement with the previous work of Beg et al. (1995b),
which suggests that RelA controls expression of inducible
NF-kB-regulated genes, but not basal gene expression.
NF-kB is known to regulate organ inflammation. Conven-
tionally, the onset or enhancement of an inflammatory
response has been linked to activation of NF-kB signaling.
Here, we show that it is not activation but functional
inhibition of RelA in the epidermis that causes an enhance-
ment of skin inflammation, as evidenced by increased ear
swelling and epidermal hyperplasia. How could inhibition of
RelA function in epidermal keratinocytes lead to an enhanced
DTH response?
One conceivable scenario would be that the RelA-deficient
epidermis alters the efficiency of sensitization to the haptens
used. Our enzyme-linked immunosorbent spot analysis has,
however, revealed that there are no significant differences
in the numbers of hapten-specific T cells in the spleens and
lymph nodes of RelAE-MUT mice and control mice (see
Supplementary Figure S1 online). Thus, increased inflamma-
tion in RelAE-MUT mice cannot be explained by differences in
the sensitization phase. As functional inhibition of RelA in our
mice is epidermis specific, epidermal keratinocytes must be
the target and possibly also the source of one or several factors
that modify their proliferative response to the inflammatory
environment, which is determined by the presence of hapten-
specific T cells. Therefore, the altered proliferative response in
the RelAE-MUT epidermis is the consequence of a direct or an
indirect communication between hapten-specific T cells and
epidermal keratinocytes. As these hapten-specific T cells are
not present in croton oil–induced inflammation, there is no
difference in the proliferative response of the epidermis.
The fact that functional RelA impairment by itself does not
lead to hyperproliferation of the epidermis suggests that
epidermal hyperplasia observed in RelAE-MUT mice is due to
an indirect mechanism, which involves factors present in the
extracellular milieu during the inflammatory response. In our
attempt to identify such factors, we focused on differences in
the regulation of pro-inflammatory cytokines. Interestingly,
upon DNFB challenge, we observed differences in the
expression of S100A8 and S100A9 proteins in both keratino-
cytes as well as in inflammatory cells in the dermis, which are,
according to morphological parameters, granulocytes. S100A8
and S100A9 proteins are produced by neutrophils, monocytes,
and keratinocytes and are known as pro-inflammatory and
chemotactic mediators in the effector phase of organ inflam-
mation (Eckert et al., 2004). They also stimulate keratinocyte
growth (Nukui et al., 2008). However, as the expression of
S100 proteins was also increased in croton oil–treated ears,
which did not show increased swelling and thickening of the
epidermis (Figures 2b and 4c), their expression is obviously
not sufficient to cause these inflammatory changes.
Nonetheless, our results provide further insights into the
regulation of S100A8/ A9 by NF-kB (Nemeth et al., 2009) and
suggest that the presence of epidermal RelA is important to
control their production in skin, which could be one of the
mechanisms to control the amplitude of an inflammatory
response. This finding is in line with previous results
showing upregulation of S100 proteins in the skin of mice
with epidermis-specific deletion of IkB kinase 2 (Benoit et al.,
2006). As S100A8 and S100A9 have recently been shown to
contribute to the pro-inflammatory cross talk between
the epidermis and dermis in psoriasis (Lee et al., 2012),
the regulatory function of NF-kB on their expression could
be a general mechanism contributing to the maintenance of
skin homeostasis (Pasparakis et al., 2002; Stratis et al.,
2006a,b).
Our study also reveals a critical role of RelA in protecting
keratinocytes from inflammation-induced apoptosis. This is in
accordance with described functions of NF-kB in the protec-
tion from cell death (Beg et al., 1995b; Seitz et al., 2000).
NF-kB regulates expression of anti-apoptotic genes such as
cellular inhibitors of apoptosis and XIAPs (Barkett and Gilmore,
1999). Expression analysis of apoptosis-related genes revealed
an increased expression of XAF1 in challenged ears of
RelAE-MUT mice. XAF1 binds XIAP and attenuates its anti-
apoptotic function, probably by sequestering XIAP in nuclear
inclusions and inhibiting its anti-caspase activity (Liston et al.,
2001). This sensitizes cells to undergo apoptosis whenever
XAF1 is overexpressed. Such a mechanism could serve as a
plausible explanation for the increase in apoptosis observed
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in challenged RelAE-MUT mice. It is conceivable that, under
inflammatory conditions, XAF1 may sensitize keratinocytes to
death receptor ligands known to be active in contact allergy,
such as tumor necrosis factor–related apoptosis-inducing
ligand or Fas ligand (Trautmann et al., 2000; Schmidt et al.,
2010) However, we have shown previously that deletion of
Fas from epidermal keratinocytes did not reduce keratinocyte
apoptosis in contact allergy and upon UVB irradiation in mice
(Hedrych-Ozimina et al., 2011).
Understanding the interplay between extracellular factors
and components of the NF-kB signaling pathway in the regu-
lation of inflammatory and apoptotic responses in the epider-
mis will be of great relevance to understand and successfully
treat potentially life-threatening skin conditions such as drug
reactions and graft versus host disease (Gilliam et al., 1996;
Lissia et al., 2010).
MATERIALS AND METHODS
Mice
All mice were maintained as per institutional guidelines. RelA-floxed
mice (Algul et al., 2007) and K14 promoter–driven Cre mice (Hafner
et al., 2004) were maintained on C57Bl/6 background. Genotyping
was performed by PCR as described previously (Rebholz et al., 2007).
Expression of mutant RelA was tested by western blotting.
Induction of a DTH response by DNFB and oxazolone challenge
and contact dermatitis by croton oil application
All experiments were performed on age-matched 8–10-week-old
female mice. To induce the DTH response, mice were anesthetized
on day 0 and the thickness of the ear was measured using a digital
caliper (Mitutoyo, Kawasaki, Japan). Subsequently, 30ml of a 0.5%
DNFB solution or 100 mg ml 1 oxazolone in acetone/olive oil (4:1)
was applied to the shaved abdomen for sensitization. On day 6, mice
were anesthetized and ear thickness was measured. Subsequently,
mice were challenged with 10ml 0.2% DNFB or 10 mg ml 1
oxazolone in acetone/olive oil (4:1) on both sides of the ear.
To induce irritative contact dermatitis, mice were anesthetized and
the thickness of the ear was measured. Subsequently, 5ml of 1%
croton oil in acetone was applied on both sides of the ear.
Ear thickness was determined after 24, 48, 72, 96, or 120 hours of
challenge/ croton oil treatment using a digital caliper. Each measure-
ment was performed three times and the mean was calculated.
Keratinocyte isolation and analysis of proliferation and apoptosis
Primary keratinocytes were isolated from newborn pups at P1 and
cultured as described previously (Tscharntke et al., 2007).
For growth curves, 30,000 primary keratinocytes were seeded per
well of a collagen-coated 24-well plate followed by trypsinization
and counting of cell numbers at different time points.
For BrdU incorporation, cells were cultured for 2 days on collagen-
coated coverslips and treated with BrdU (1mM) for 30 minutes at 37 1C
followed by fixation, immunostaining for BrdU, and nuclear staining
with 4’,6-diamidino-2-phenylindole. Positive cells were counted and
expressed as a ratio of BrdU-positive cells to the total cell population.
Immunostaining
K14, K10, Loricrin (Covance, Princeton, NJ, 1:1,000, 1:100, 1:500,
respectively), CD11b (eBiosciences, Frankfurt, Germany, 1:500),
F4/80 (AbD Serotech, Oxford, UK, 1:50), CD3 (Chemicon, Temecula,
CA, 1:1,000), and Caspase-3 (Cell Signaling Technology, Denver,
CO, 1:200) stainings were performed on cryosections as described
before (Stratis et al., 2006b; Hedrych-Ozimina et al., 2011). Nuclei
were stained with 4’,6-diamidino-2-phenylindole. S100A8 staining
(Abcam, Cambridge, UK, 1:200) on paraffin sections and S100A9
staining (Abcam, 1:100) on acetone-fixed frozen sections were
performed after incubation with an endogenous peroxidase blocker
(Dako, Hamburg, Germany) and 10% goat serum, followed by
visualization with HRP-AEC (Dako) and hematoxylin and eosin
counterstaining. BrdU staining on tissue sections was performed as
described previously (Behrendt et al., 2012).
Cleaved caspase-3 was stained on 4% paraformaldehyde-fixed
keratinocytes, permeabilized and blocked with 0.2% Triton-X and
10% goat normal serum in 1% BSA/0.2% Triton-X/phosphate-buf-
fered saline using a primary antibody against cleaved caspase-3 (Cell
Signaling Technology, 1:200) and Alexa-488–conjugated anti-rabbit
IgG (Molecular Probe, Paisley, UK). Nuclei were stained with 4’,6-
diamidino-2-phenylindole.
Western blot
Epidermis and ear skin samples were homogenized using a
mixer mill MM 400 (Retsch GmbH, Haan, Germany) and extracted
in RIPAþ buffer (50 mM Tris, 5 mM EDTA, 1% Triton-X-100, 1%
NP-40, 0.1% SDS, 0.5% deoxycholate, 20 mM leupeptin, 1 mM
phenylmethylsulfonyl fluoride, 0.5 mg ml 1 soybean trypsin inhibi-
tor, 0.5 mM NaVO3, and 10 mg ml
 1 P-nitrophenylphosphate).
Cultured keratinocytes were lysed in situ using the same buffer.
Lysates were centrifuged at 16,000g for 10 minutes at 4 1C and
supernatants were used for western blot after standard protein
quantification.
In all, 30–50mg of protein was resolved on 4–12% NuPAGE
SDS-PAGE (Invitrogen, Carlsbad, CA) and blotted onto nitrocellulose
or polyvinyldiene fluoride membranes using the iBlot transfer system
(Invitrogen). After blocking with Roche block (Roche Applied
Science, Indianapolis, IN, 1:10) the membrane was probed with
polyclonal rabbit anti-p65 (Cell signaling Technology, 1:1,000) or
anti-XAF1 (Abcam, 1:500), monoclonal rabbit anti-S100A8 or anti-
S100A9 (Abcam, 1:2,000 and 1:1,000, respectively), and monoclonal
mouse anti-actin (MP Biomedicals, Aurora, OH, 1:6,000) antibodies.
Immunoreactive proteins were visualized by chemiluminescence
(PerkinElmer, Waltham, MA; Pierce Thermo Fisher Scientific, Rock-
ford, IL) on an Uvichemi chemiluminescence documentation system
(Biometra, Cambridge, UK).
IFN-c enzyme-linked immunosorbent spot assay
Isolated inguinal lymph node cells and splenocytes were cultured
with or without 100mg ml 1 2,4-dinitrobenzenesulfonic acid for
24 hours in RPMI medium supplemented with 10% fetal calf serum.
For detection, the Mouse IFN-g ELISPOT kit (R&D Systems, Minnea-
polis, MN) was used.
Microarray analysis
Microarray data were generated using the Agilent whole
mouse–genome oligo microarrays (one color, Miltenyi Biotec,
Cologne, Germany). The method and the raw data are submitted to
the NCBI Gene Expression Omnibus with accession number
GSE56067.
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Statistical analysis
Significance of differences between the samples was calculated using
the Student’s t-test. A P-value p0.05 was considered as statistically
significant. *P-value p0.05, **P-value p0.01, ***P-value p0.001.
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